David Baker

3.0k total citations
30 papers, 918 citations indexed

About

David Baker is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, David Baker has authored 30 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 9 papers in Emergency Medicine. Recurrent topics in David Baker's work include HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (9 papers). David Baker is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (9 papers). David Baker collaborates with scholars based in Australia, United States and United Kingdom. David Baker's co-authors include Andrew Carr, Sean Emery, Matthew Law, David A. Cooper, Letitia Bradford, Michael D. Ries, Lisa A. Pruitt, Gary David Rogers, Dianne Carey and DA Cooper and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

David Baker

28 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Baker Australia 15 467 441 346 251 112 30 918
Jean‐Marie Ragnaud France 20 692 1.5× 404 0.9× 577 1.7× 273 1.1× 57 0.5× 40 1.3k
Mark Oette Germany 20 591 1.3× 120 0.3× 524 1.5× 269 1.1× 97 0.9× 66 1.1k
Vania Giacomet Italy 24 963 2.1× 630 1.4× 484 1.4× 436 1.7× 126 1.1× 107 1.7k
Marialuisa Partisani France 15 598 1.3× 391 0.9× 297 0.9× 351 1.4× 97 0.9× 38 1.1k
Lambert Assoumou France 21 858 1.8× 466 1.1× 842 2.4× 240 1.0× 80 0.7× 78 1.4k
Pierfrancesco Grima Italy 15 234 0.5× 183 0.4× 193 0.6× 178 0.7× 33 0.3× 46 575
Stefania Bernardi Italy 18 511 1.1× 147 0.3× 434 1.3× 317 1.3× 34 0.3× 63 978
Robert Delapenha United States 14 547 1.2× 186 0.4× 388 1.1× 224 0.9× 66 0.6× 22 867
Jorge Pinto Brazil 18 540 1.2× 186 0.4× 239 0.7× 330 1.3× 44 0.4× 44 979
Negar Aliabadi United States 15 518 1.1× 247 0.6× 121 0.3× 159 0.6× 63 0.6× 43 847

Countries citing papers authored by David Baker

Since Specialization
Citations

This map shows the geographic impact of David Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baker more than expected).

Fields of papers citing papers by David Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baker. The network helps show where David Baker may publish in the future.

Co-authorship network of co-authors of David Baker

This figure shows the co-authorship network connecting the top 25 collaborators of David Baker. A scholar is included among the top collaborators of David Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Baker. David Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martinello, Marianne, Jeffrey J. Post, Robert Finlayson, et al.. (2024). Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014–2023). Open Forum Infectious Diseases. 11(12). ofae665–ofae665. 1 indexed citations
3.
4.
5.
Bavinton, Benjamin R., Stefanie Vaccher, Fengyi Jin, et al.. (2021). High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(4). 1040–1047. 16 indexed citations
6.
Martinello, Marianne, Jasmine Yee, Phillip Read, et al.. (2020). Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV. AIDS. 34(9). 1347–1358. 16 indexed citations
7.
8.
Martinello, Marianne, Jasmine Yee, Sofia Bartlett, et al.. (2019). Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study. Clinical Infectious Diseases. 71(6). 1502–1510. 43 indexed citations
9.
Martinello, Marianne, Jasmine Yee, Sofia Bartlett, et al.. (2019). SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia. Journal of Hepatology. 70(1). e734–e734. 1 indexed citations
10.
Petoumenos, Kathy, Robin Huang, Jennifer Hoy, et al.. (2017). Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years—The Australian Positive & Peers Longevity Evaluation Study (APPLES). PLoS ONE. 12(9). e0184583–e0184583. 37 indexed citations
11.
Bloch, Mark, et al.. (2014). Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks. HIV Medicine. 15(6). 373–380. 53 indexed citations
12.
Guy, Rebecca, Carol El‐Hayek, Christopher K. Fairley, et al.. (2013). Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia. PLoS ONE. 8(8). e71436–e71436. 27 indexed citations
13.
Baker, David, et al.. (2012). Communication training for international graduates. The Clinical Teacher. 9(5). 325–329. 18 indexed citations
14.
Martin, Allison, Janaki Amin, Sean Emery, et al.. (2011). Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine. PLoS ONE. 6(10). e26885–e26885. 14 indexed citations
15.
Carey, Dianne, David Baker, Kathy Petoumenos, et al.. (2009). Poly‐l‐lactic acid for HIV‐1 facial lipoatrophy: 48‐week follow‐up. HIV Medicine. 10(3). 163–172. 12 indexed citations
16.
Emery, Sean, Anthony D. Kelleher, Cassy Workman, et al.. (2007). Influence of IFNγ Co-Expression on the Safety and Antiviral Efficacy of Recombinant Fowlpox Virus HIV Therapeutic Vaccines Following Interruption of Antiretroviral Therapy. Human Vaccines. 3(6). 260–267. 24 indexed citations
17.
Carey, Dianne, David Baker, Gary David Rogers, et al.. (2007). A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial Lipoatrophy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(5). 581–589. 33 indexed citations
18.
Carr, Andrew, Cassy Workman, Dianne Carey, et al.. (2004). No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. The Lancet. 363(9407). 429–438. 186 indexed citations
19.
Miller, J. Philip, Andrew Carr, Sean Emery, et al.. (2003). HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Medicine. 4(3). 293–301. 159 indexed citations
20.
Baker, David, et al.. (1999). Study of fatigue resistance of chemical and radiation crosslinked medical grade ultrahigh molecular weight polyethylene. Journal of Biomedical Materials Research. 46(4). 573–581. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Ragnaud Breakdown of academic impact, for papers by Mark Oette Breakdown of academic impact, for papers by Vania Giacomet Breakdown of academic impact, for papers by Marialuisa Partisani Breakdown of academic impact, for papers by Lambert Assoumou Breakdown of academic impact, for papers by Pierfrancesco Grima Breakdown of academic impact, for papers by Stefania Bernardi Breakdown of academic impact, for papers by Robert Delapenha Breakdown of academic impact, for papers by Jorge Pinto Breakdown of academic impact, for papers by Negar Aliabadi
Rankless by CCL
2026